01 June 2015, Maidenhead, UK – IAOCR, a leading provider of independently recognized, competence-based accreditation, consultancy and accredited training for clinical research professionals, welcomes the new EU regulation on clinical trials of medicinal products for human use as an important step for the safe implementation of clinical trials. The new regulation is designed to provide a more streamlined approach to the conduct of trials with greater public openness about each trial and the results they produce. The implementation date is planned for the 28th May 2016.
“IAOCR is delighted the EU has addressed the clear need for better regulation of clinical trials, however there is still a long way to go,” commented Martin Robinson PhD, Executive VP & IAOCR Ambassador. “These changes will work towards ensuring patient safety is at the forefront of clinical trials but the competence of those undertaking the trials is also required to ensure a robust, proficient and safe system is in place across Europe. IAOCR is committed to ensuring clinical researchers are qualified by education, training and experience and believes accreditation helps to ensure that Good Clinical Practice (GCP) is adhered to and that patients’ rights and wellbeing are upheld.”
The new regulation was approved by the European Parliament in April last year and has now been published in the official Journal of the European Union. It replaces directive 2001/20/EC – the Clinical Trial Directive which has been in place for almost a decade. The benefits associated with the new regulation include a single approval portal, standardized content of clinical trial applications, information about subject protection and informed consent, more stringent requirements for reporting trial progress and greater transparency about clinical trials.
The regulation will be applied in full in all member states, with no need for separate national legislation and this will result in consistent and uniform application throughout EU allowing the EU Commission to conduct controls in Member States making sure that rules are properly supervised and enforced.
IAOCR’s Qualified Clinical Research Trainers have delivered training programs to over 250 clinical research organizations spanning five continents. They have practical working experience in clinical research and have passed comprehensive competence assessments. For more information about our focused training programs that significantly improve performance please visit http://iaocr.com/training.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.